Testosterone replacement therapy and prostate cancer: A word of caution

被引：19
|
作者：
Brand T.C. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
来源：
Current Urology Reports | 2007年 / 8卷 / 3期
关键词：
Prostate Cancer; Testosterone; Digital Rectal Examination; Free Testosterone; Prostatic Intraepithelial Neoplasia;
D O I：
10.1007/s11934-007-0004-x
中图分类号：
学科分类号：
摘要：
The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2007 by Current Medicine Croup LLC.
引用
收藏
页码：185 / 189
页数：4
相关论文
共 50 条
  • [31] Testosterone replacement therapy
    Barbonetti, Arcangelo
    D'Andrea, Settimio
    Francavilla, Sandro
    ANDROLOGY, 2020, 8 (06) : 1551 - 1566
  • [32] Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth
    Rinnab, L.
    Gust, K.
    Hautmann, R. E.
    Kuefer, R.
    UROLOGE, 2009, 48 (05): : 516 - 522
  • [33] Prostate Risk and Monitoring During Testosterone Replacement Therapy
    Bhasin, Shalender
    Thompson, Ian M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (08) : 1975 - 1983
  • [34] Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy
    Coward, Robert M.
    Simhan, Jay
    Carson, Culley C., III
    BJU INTERNATIONAL, 2009, 103 (09) : 1179 - 1183
  • [35] Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism
    Santella, Christina
    Renoux, Christel
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2019, 188 (09) : 1666 - 1673
  • [36] Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    D C Gould
    R S Kirby
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 14 - 18
  • [37] Testosterone therapy for men risk for or with history of prostate cancer
    Morgentaler A.
    Current Treatment Options in Oncology, 2006, 7 (5) : 363 - 369
  • [38] The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis
    Y Cui
    H Zong
    H Yan
    Y Zhang
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 132 - 143
  • [39] Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
    Lenfant, Louis
    Leon, Priscilla
    Cancel-Tassin, Geraldine
    Audouin, Marie
    Staerman, Frederic
    Roupret, Morgan
    Cussenot, Olivier
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 661 - 670
  • [40] Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould, DC
    Kirby, RS
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 14 - 18
12345